Table 2.
The correlation analysis of TMSB4X expression and clinicopathological features in HNSCC cohort.
| Features | Case no | TMSB4X expression | P value | |||
|---|---|---|---|---|---|---|
| Low(n = 27) (%) | High(n = 59) (%) | |||||
| Age at diagnosis | ||||||
| <65 y | 70 | 22 | 31.4% | 48 | 68.6% | 0.989 |
| >=65 y | 16 | 5 | 31.3% | 11 | 68.8% | |
| Gender | ||||||
| Male | 79 | 24 | 30.4% | 55 | 69.6% | 0.495 |
| Female | 7 | 3 | 42.9% | 4 | 57.1% | |
| T Status | ||||||
| T1 + T2 | 60 | 22 | 36.7% | 38 | 63.3% | 0.110 |
| T3 + T4 | 26 | 5 | 19.2% | 21 | 80.8% | |
| N Status | ||||||
| N0 | 59 | 18 | 30.5% | 41 | 69.5% | 0.793 |
| N1-N3 | 27 | 9 | 33.3% | 18 | 66.7% | |
| M Status | ||||||
| M0 | 84 | 27 | 32.1% | 57 | 67.9% | 0.333 |
| M1 | 2 | 0 | 0.0% | 2 | 100.0% | |
| Clinical Stage | ||||||
| Stage I + II | 45 | 15 | 33.3% | 30 | 66.7% | 0.685 |
| Stage III + IV | 41 | 12 | 29.3% | 29 | 70.7% | |
| Recurrence | ||||||
| No | 32 | 15 | 46.9% | 17 | 53.1% | 0.017* |
| Yes | 54 | 12 | 22.2% | 42 | 77.8% | |